Related Reading

Related Reading

Back to Document

Clinical Trials: Should You Participate?
Hope on the Horizon for Breast Cancer
Solving the Breast Cancer Puzzle
Stay Healthy After Breast Cancer
Can I Get Checked for Breast Cancer Before I Have Symptoms?
Can I Survive Breast Cancer? What Is My Prognosis?
Ductal Carcinoma
Exercising After Breast Cancer: Moving Toward Health
Finding Out You Have Breast Cancer
How Does My Doctor Know I Have Breast Cancer?
MRIs for Breast Cancer Screening—Who Needs Them?
Myths About What Causes Breast Cancer
Questions to Ask About Treatment for Breast Cancer
Tests That Help Evaluate the Traits of Your Breast Cancer
The Soy and Breast Cancer Controversy: Cause for Concern?
Tips for Feeling Your Best During Treatment for Breast Cancer
Understanding Your Grade and Stage of Breast Cancer
Understanding Your Type of Breast Cancer
What Are the Symptoms of Breast Cancer?
What Can I Do if I Am at Risk for Breast Cancer?
What Happens During Targeted Therapy for Breast Cancer
What Is Breast Cancer?
What to Know About Combination Therapy for Breast Cancer
What to Know About Inflammatory Breast Cancer (IBC)
What to Know About Surgery for Breast Cancer
What to Know About Targeted Therapy for Breast Cancer
What to Know About Your Treatment Choices for Breast Cancer
Reducing Your Risk for Breast Cancer
Aromatase Inhibitors for Breast Cancer
Breast Cancer: What Happens After Reconstructive Surgery
Breast Cancer—Understanding Genetic Testing
Do What You Can to Ease Side Effects of Treatment and Symptoms for Breast Cancer
Goal of Chemotherapy for Breast Cancer
How You Get Radiation for Breast Cancer
How Your Doctor Uses Biopsies to Make Your Diagnosis of Breast Cancer
If You Are Having Hormonal Therapy
Making the Decision to Have Breast Reconstruction After a Mastectomy for Breast Cancer
Making the Decision to Have Hormone Therapy for Breast Cancer
Ovarian Ablation as Hormone Therapy for Breast Cancer
Sex and Cancer: Questions for Your Doctor
Statistics About Breast Cancer
Taking Care of Your Incision After Breast Surgery
The 'Chemobrain' Phenomenon in Breast Cancer
Understanding Research Studies
What Happens During Chemotherapy for Breast Cancer
What Happens During Hormone Therapy for Breast Cancer
What Happens During Radiation Therapy for Breast Cancer
What to Expect After Radiation Treatment for Breast Cancer
What to Expect After Surgery for Breast Cancer
What to Expect After Taking Hormone Therapy Drugs for Breast Cancer
What You Need to Know About Digital Mammography
What You Need to Know About Hormone Therapy for Breast Cancer
When Breast Cancer Spreads to the Bones
Should You Consider Preventive Drugs for Breast Cancer?
Certain Factors Help Predict Invasive Breast Cancer
Am I at Risk for Breast Cancer?
Hormonal Therapy: Managing Side Effects in Women
Should You Be Tested for the Breast Cancer Gene?

Broward Health Medical Center Clinical Trials Program focuses on having available clinical trials to improve cancer care by finding better ways to treat cancer and help cancer patients.

The decision to enroll in a clinical trial is voluntary and one that should be made with the close consultation of a physician.

For further information, please contact the Cancer Research Department:

Medical Hematologist / Oncologists
Radiation Oncologists
Research Nurses & Research Associates

Rowena Dimayuga, RN MSN CCRP
Melissa Hoag, Clinical Research Associate
Donna Stefinsky, RN CCRC 

Clinical Trials List

Updated: March 11, 2014

Breast

ECOG 3108: A Phase II Prospective Trial Correlating Progression Free Survival with CYP2D6 Activity in Patients with Metastatic Breast Cancer Treated with Single Agent Tamoxifen
Principal Investigator: Archana Maini, MD
Status: Temporarily closed to accrual

ECOG 2108: A Randomized Phase III Trial of Value of Early Local Therapy for the Intact Primary Tumor in Patients with Metastatic Breast Cancer
Principal Investigator: Barry Berman, MD
Status: Actively Recruiting

NSABP-B47: A Randomized Phase III Trial of Adjuvant Therapy Comparing Chemotherapy Alone (Six Cycles of Docetaxel Plus Cyclophosphamide or Four Cycles of Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel) to Chemotherapy Plus Trastuzumab in Women with Node-Positive or High-Risk Node-Negative HER2-Low Invasive Breast Cancer
Principal Investigator: Barry Berman, MD
Status: Actively Recruiting

Agendia PROMIS Study: PROMIS: PRospective study Of MammaPrint in breast cancer patients with an Intermediate recurrence Score (18-30 Oncotype DX)
Principal Investigator: Archana Maini, MD
Status: Actively Recruiting

Back to the Top

Gastroesophageal

SWOG 1201: A Randomized Ph II Pilot Study Prospectively Evaluating Tx  for Patients Based on ERCC1 (Excision Repair Cross-Complementing 1) for Advanced/ Metastatic Esophageal, Gastric or Gastroesophageal Junction (GEJ) Cancer.
Principal Investigator: Archana Maini, MD
Status: Actively Recruiting

Head & Neck

RTOG 1016: Phase III Trial of Radiotherapy plus Cetuximab versus Chemoradiotherapy in HPV-Associated Oropharynx Cancer
Principal Investigator: Marshal Lieberfarb, MD
Status: Actively Recruiting

SOLIGENIX: Phase II Double-Blind, Randomized, Placebo-Controlled, Dose-Escalating Multicenter Study of SGX942 for the Attenuation of Oral Mucositis in Patients Being Treated with Concomitant Chemoradiation for the Treatment of H&N SCC
Principal Investigator: Archana Maini, MD
Status: COMING SOON

Back to the Top

Lung

ECOG 5508: Randomized Phase III Study of Maintenance Therapy with Bevacizumab, Pemetrexed, or a Combination of Bevacizumab and Pemetrexed Following Carboplatin, Paclitaxel and Bevacizumab for Advanced NSCLC
Principal Investigator: Archana Maini, MD
Status: Actively Recruiting

Amgen Protocol 20070782: A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Long-term Safety and Efficacy of Darbepoetin Alfa Administered at 500 μg Once-Every-3-Weeks in Anemic Subjects With Advanced Stage Non-small Cell Lung Cancer Receiving Multi-cycle Chemotherapy
Principal Investigator: Archana Maini, MD
Status: Actively Recruiting

Back to the Top

Multiple Myeloma

CELGENE 007: Phase III, Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Pomalidomide, Bortezomib and Low-Dose Dex vs. Bortezomib and Low-Dose Dex in Subjects with Relapsed or Refractory Multiple Myeloma (MM)
Principal Investigator: Archana Maini, MD
Status: Actively Recruiting

Back to the Top

Prostate

RTOG 0815: A Phase III Prospective Randomized Trial of Dose-Escalated Radiotherapy with/without Short-term Androgen Deprivation Therapy for Patients with Intermediate-Risk Prostate Cancer
Principal Investigator: Evan Landau, MD
Status: Actively Recruiting

SWOG 1216: A Phase III Randomized Trial Comparing Androgen deprivation therapy + TAK-700 with Androgen deprivation therapy + Bicalutamide in Patients with Newly Diagnosed Metastatic Hormone Sensitive Prostate Cancer
Principal Investigator: Archana Maini, MD
Status: Actively Recruiting

Back to the Top

Other

BHMC 001: A Prospectively Acquired Database of Head and Neck Cancer Patients Receiving Radiation Therapy
Principal Investigator: Evan Landau, MD
Status:
Actively Recruiting

Please call the Principal Investigator or Study coordinator with any questions or potential subjects.

Back to the Top